The Expressions of Matrix Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinase-1 in Scar Endometriosis and Full Term Endometrium.

In: Obstetrics & Gynecology Science · 2002 · vol. 45(8) , pp. 1311–1316 · W2400478326
article OA: closed CC0
View on OpenAlex
AI-generated summary by gemini-2.5-flash-lite, 2026-08-04

This study investigated matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) expression in scar endometriosis and full-term endometrium, finding MMP-9 expressed in both but TIMP-1 in neither.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective : Endometriosis in a surgical scar following cesarian section is rare condition. And its pathogenesis has not been well established, The purpose of this study is to observe the expressions of matrix metalloproteinase-9 (MMP-9) and tissue inhibitors of metalloproteinase-I (TIMP-1) in scar endometriosis and full term endometrium during cesarian section. Methods: Nineteen scar endometriotic tissue and ten full term pregnant endometrium during cesarian section were investigated by immunohistochemical stain for MMP-9 and T1MP-1. Results: The MMP-9 was expressed in eleven of nineteen scar endometriotic tissue (57.9%) and eight of ten full term pregnant endometrium (80.0%). The T1MP-1 was not expressed in both scar endometriotic tissue and full term pregnant endometrium. Conclusion : These results suggest that the relationship between MMP-9 and T1MP-1 might play a role of pathogenesis of scar endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK